MedTrace Logo

Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia

NCT00403247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-08-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether individuals with schizophrenia who will take a high dose of the B-vitamins folate, B12 and pyridoxine, may experience improvement in their symptoms.

Conditions

Interventions

DIETARY_SUPPLEMENT

Capsule with folate, Vitamin B12 & pyridoxine

OTHER

placebo

placebo capsule

Sponsors & Collaborators

  • Stanley Medical Research Institute

    collaborator OTHER

  • Nathan Kline Institute for Psychiatric Research

    lead OTHER

Principal Investigators

  • William M Greenberg, M.D. · The Nathan Kline Institute for Psychiatric Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00403247 on ClinicalTrials.gov